Provider PerspectivesHow are the English Stop Smoking Services responding to growth in use of electronic cigarettes?
Introduction
The number of countries around the world offering some form of Stop Smoking Service to smokers who wish to quit is accumulating steadily, although these often differ extensively in structure and outreach [1]. Perhaps one of the most comprehensive is the United Kingdom Stop Smoking Services established in 1999, which have been instrumental in reducing smoking rates [2] and have served as a model for other countries. These services are under the direction of local authorities, with each configuring itself on the basis of national guidelines. The services aim to provide evidence-based behavioural support and access to smoking cessation medication [3], [4].
With the release of the National Institute of Health and Care Excellence guidance on tobacco harm reduction in June 2013, the English Stop Smoking Services may be extended to offer support and guidance to smokers who are unable or unwilling to stop smoking [5]. The guidance covers two main forms of harm reduction – smoking reduction and temporary abstinence – which have both been shown to increase the propensity of smokers to stop, particularly if supported by licenced nicotine containing products [6], [7], [8]. Although this advice may take many forms, one recommendation is that guidance on harm reduction is incorporated into the brief advice given by health-care professionals prior to service attendance. This will ensure that disruption to the services does not occur and that the message is still that of complete abstinence [9]. However, smokers attempting harm reduction should be encourage to attend the services when they feel ready to quit smoking and given support to stop abruptly (note: although clinical trials have found that gradual cessation has similar efficacy as abrupt cessation, it appears to be less effective in the real world [10], [11], [12]).
The National Institute of Clinical and Care Excellence guidance also acknowledged the potential contribution of electronic cigarettes (e-cigarettes) to tobacco harm reduction, but would only advocate this approach if they became licenced medicines in the UK. Studies have shown that these devices are becoming increasingly popular, and that they may help users to reduce or quit smoking [13], [14], [15], [16], [17], [18], [19], [20]. They also deliver clinically significant levels of nicotine into the blood, albeit, at least for some smokers, at a much lower level than traditional tobacco products [21], [22], [23]. Potentially harmful constituents have been identified in some cartridges [24], [25]; though levels are much lower than those found in cigarettes [26].
However, a major limitation with many of these studies is that they were based on surveys which recruited smokers from e-cigarette forums who are likely to hold more favourable attitudes towards such products. This is evident in the study by Dawkins et al. [23], where the authors reported that 74% of their sample had not smoked for several weeks since using e-cigarettes. This far exceeds what would be expected for currently available efficacious treatments [27]. Much of the data so far on safety and nicotine intake is also based on clinical trials, thus results may not play out in the real world where smokers will not generally be provided with e-cigarettes free of charge.
In June 2013, the Medicines and Healthcare products Regulatory Agency finalised their consultation on e-cigarettes and reached the decision that they should be regulated as medicines in the UK by 2016, in the belief that licensing would improve their safety and effectiveness [28]. This has put the UK at the forefront of the debate on e-cigarettes, with many other countries deliberating over their use or banning/imposing heavy restrictions, including Australia, Brazil, Lebanon, France, the US and Singapore. Reasons for this hostility include the belief that they contain harmful substances, that they may encourage higher consumption of nicotine and that they will act as a gateway to smoking.
With the release of guidelines on harm reduction, and these regulatory changes to e-cigarettes, there is a need to determine the role that Stop Smoking Services will play. A first step, and the aim of this paper, is to ascertain the procedures stop smoking practitioners and managers have in place to record and advise smokers about the use of electronic cigarettes and to assess their beliefs about the prevalence and reasons for e-cigarette use among their clients.
It is important to discover whether Stop Smoking Services have provisions in place to record e-cigarette use, since careful monitoring will allow for the analysis of the impact of e-cigarettes on quit rates over time and other significant clinical outcomes. It might be hypothesised that since they are not currently licensed, and therefore not available on prescription, that few if any monitoring procedures will be implemented. It is similarly important to determine the advice given by Stop Smoking Practitioners to ensure that the Stop Smoking Services are maintaining an evidence-based approach; since although there is strong endorsement for evidence-based practice in health-care fields, its use is often lacking [29], [30], [31], [32].
One reason for this is that health-care professionals’ personal beliefs often conflict with the evidence base and are more likely to influence practice [33], [34], [35]. For example, previous research shows that health-care professionals hold erroneous views about nicotine containing products and harm reduction generally, and that these beliefs are associated with the advice offered to smokers [36], [37]. Thus if similar views are established about e-cigarettes it is plausible that Stop Smoking Practitioners may advise against their use. This situation may change in the UK in light of the recent guidance and recommendations by the National Institute of Clinical and Care Excellence and the Medicines and Healthcare products Regulatory Agency, and with training on e-cigarettes and harm reduction offered to Stop Smoking Practitioners by organisations such as the National Centre for Smoking Cessation and Training.
Finally, it is of interest to assess their beliefs about how many clients are using e-cigarettes and the reasons for their use, in order to inform future polices and the training offered to Stop Smoking Practitioners. Previous research suggests that smokers use e-cigarettes as they are less toxic than tobacco, to quit smoking or avoid relapsing, to deal with cravings for tobacco, during periods of temporary abstinence, for smoking reduction, and because they are cheaper than cigarettes [14], [15]. If a substantial proportion of e-cigarette users are attempting harm reduction then the prevalence of use in Stop Smoking Services may be low, on the basis that smokers who use nicotine containing products for harm reduction often do not approach health-care professionals and hold hostile beliefs about the services offered to smokers [38], [39].
The specific questions addressed by the current study are as follows:
- 1.
Do stop smoking services have procedures in place to record clients’ cigarette use?
- 2.
What advice do stop smoking practitioners give their clients about e-cigarettes and is this consistent with the recommendations given by managers of Stop Smoking Services?
- 3.
How many clients have asked questions about e-cigarettes, tried them, or report regularly using them?
- 4.
What reasons do smokers give Stop Smoking Practitioners for using of e-cigarettes?
Section snippets
Procedure
An email was sent to all Stop Smoking Managers in England on behalf of the researchers by the National Centre for Smoking Cessation and Training. All managers were requested to take part and to forward the link to their staff. An email was also sent to all Stop Smoking Practitioners on the National Centre for Smoking Cessation and Training database and to all those that completed the 2011 survey but were not on the training database. Emails were personalised where possible i.e. addressed
Results
One hundred and fifty-five managers were contacted, of which 82.6%% (n = 128) agreed to participate in the online survey. Of these, 70 were excluded as they terminated the survey early and did not reach the questions on e-cigarettes. This resulted in a final sample of 58 managers (37.4% response rate). Seventy-eight per cent (n = 45) of managers were female. The majority were employed by a Primary Care Trust or Hospital Trust (39.7%, n = 23) and on average had managed a Stop Smoking Service for 6.8
Discussion
The current study found that few Stop Smoking Services have systems in place to record e-cigarette use, but that a large majority of service managers do provide practitioners with recommendations as to the advice they should give smokers about e-cigarettes. Common advice was that e-cigarettes are not currently approved or licensed and more research is required on their efficacy and safety. The actual advice that practitioners gave their clients was similar, except many also raised safety
Conflicts of interest
EB and JB have received unrestricted funding from Pfizer. RW and AMcE have undertaken research and consultancy for companies that develop and manufacture smoking cessation medications. RW and AMcE have a share of a patent for a novel nicotine delivery device. LB's and EB'S posts at the time of data collection was funded by the National Centre for Smoking Cessation and Training.
Acknowledgements
This study was funded by the National Centre for Smoking Cessation and Training (NCSCT). A place at the UK National Smoking Cessation Conference (UKNSCC) was offered by the UKNSCC organising committee as an incentive for participation.
References (50)
- et al.
Assessing the association between the use of NRT for smoking reduction and attempts to quit smoking using propensity score matching
J Drug Alcohol Depend
(2012) - et al.
Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance
Am J Prev Med
(2011) - et al.
Electronic cigarettes as a smoking-cessation tool: results from an online survey
Am J Prev Med
(2011) - et al.
Barriers to implementing the evidence-based in for NHS therapies
Physiotherapy
(2001) I believe therefore I practise
The Lancet
(1996)- et al.
A survey of tobacco dependence treatment services in 121 countries
Addiction
(2013) Smoking kills: a white paper on tobacco
(1998)Local stop smoking services: key updates to the 2011/12 service delivery and monitoring guidance for 2012/13
(2013)- et al.
Smoking cessation guidelines for health professionals—a guide to effective smoking cessation interventions for the health care system
Thorax
(1998) - National Institute of Clinical and Care Excellence. Tobacco – harm reduction. Accessed: 2013-07-15 (Archived by...
Does use of nicotine replacement therapy while continuing to smoke undermine cessation?: a systematic review
J Smok Cess
Effectiveness and safety of Nicotine Replacement Therapy assisted reduction to stop smoking: systematic review and meta-analysis
Brit Med J
Key updates to the 2011/12 service delivery and monitoring guidance for 2012/13
Does how you quit affect success? A comparison between abrupt and gradual methods using data from the International Tobacco Control Policy Evaluation Study
Nicotine Tob Res
Smoking cessation and smoking patterns in the general population: a 1-year follow-up
Addiction
Reduction versus abrupt cessation in smokers who want to quit
Cochrane Database Syst Rev
Electronic cigarettes: a survey of users
BMC Public Health
Electronic cigarette: users profile, utilisation, satisfaction and perceived efficacy
Addiction
Interviews with “vapers”: Implications for future research with electronic cigarettes
Nicotine Tob Res
Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6 month pilot study
BMC Public Health
Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series
J Med Case Rep
Clinical laboratory assessment of the abuse liability of an electronic cigarette
Addiction
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
Tob Control
‘Vaping’ profiles and preferences: an online survey of electronic cigarette users
Addiction
Cited by (19)
Smokers’ use of electronic cigarettes before, during, and in the month after hospitalization. Findings from the Helping HAND 2 Study
2019, Addictive BehaviorsCitation Excerpt :Although e-cigarette use is not risk-free and the long-term health risks are unknown, they may aid cessation (National Academies of Sciences, 2018), although evidence from double-blind RCTs to demonstrate this is limited. In the general population of smokers, e-cigarette use is associated with younger age, higher education, White ethnicity, more nicotine dependence and greater interest in quitting, defined as making a recent quit attempt and being a recent ex-smoker (Beard, Brose, Brown, West, & McEwen, 2013; Biener & Hargraves, 2015; Brown et al., 2014; Delnevo et al., 2016). E-cigarette use is relatively common among U.S. adults with tobacco-attributable chronic diseases, who may sometimes require hospitalization (Kruse, Kalkhoran, & Rigotti, 2017).
Overview of Electronic Nicotine Delivery Systems: A Systematic Review
2017, American Journal of Preventive MedicineCitation Excerpt :Secondhand vape studies show that non-users may be exposed to nicotine in vapor, but at lower levels than when exposed to smoke. One hundred eighty-eight articles have addressed consumer perceptions of ENDS.145,192–194,214,241,288,299,320,323–505 Awareness of ENDS has increased among U.S. adults since 2009,323,339,362,378,384,386,388,391,394,395,440 with 86.4% of the U.S. population aware of these products in 2013.440
Treatment manuals, training and successful provision of stop smoking behavioural support
2015, Behaviour Research and TherapyCitation Excerpt :They were asked to give an estimate. The survey also included questions related to other aspects of behavioural support delivered by practitioners that are not analysed in the present study (e.g. use and advice on electronic cigarettes (Beard, Brose, Brown, West, & McEwen, 2014) and water pipes, medications offered, practitioner's views on changes to the structure of public health in England, etc.) Mean success rates were compared across different responses for each question using t-test and ANOVAs, with significance levels set to 0.05.
'It's a bit of a grey area': Challenges faced by stop smoking practitioners when advising on e-cigarettes
2019, Journal of Smoking CessationKnowledge, attitudes and beliefs towards e-cigarettes among e-cigarette users and stop smoking advisors in South East England: A qualitative study
2018, Primary Health Care Research and Development